284 related articles for article (PubMed ID: 23469574)
1. Management of abnormal uterine bleeding in women with mechanical heart valve prosthesis and anticoagulant therapy.
Saha PK; Rakshit BM; Jana N; Dutta S; Roy SB; Sengupta G
J Indian Med Assoc; 2011 Dec; 109(12):908-11. PubMed ID: 23469574
[TBL] [Abstract][Full Text] [Related]
2. Current treatment of dysfunctional uterine bleeding.
Bongers MY; Mol BW; Brölmann HA
Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
[TBL] [Abstract][Full Text] [Related]
3. The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids.
Machado RB; de Souza IM; Beltrame A; Bernardes CR; Morimoto MS; Santana N
Gynecol Endocrinol; 2013 May; 29(5):492-5. PubMed ID: 23461277
[TBL] [Abstract][Full Text] [Related]
4. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
5. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
[TBL] [Abstract][Full Text] [Related]
6. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
[TBL] [Abstract][Full Text] [Related]
7. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years.
Glasser MH; Heinlein PK; Hung YY
J Minim Invasive Gynecol; 2009; 16(6):700-7. PubMed ID: 19896596
[TBL] [Abstract][Full Text] [Related]
8. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
9. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension.
Wamsteker K; Emanuel MH; de Kruif JH
Obstet Gynecol; 1993 Nov; 82(5):736-40. PubMed ID: 8414318
[TBL] [Abstract][Full Text] [Related]
10. Management of Abnormal Uterine Bleeding with Emphasis on Alternatives to Hysterectomy.
Billow MR; El-Nashar SA
Obstet Gynecol Clin North Am; 2016 Sep; 43(3):415-30. PubMed ID: 27521876
[TBL] [Abstract][Full Text] [Related]
11. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].
Cancelo Hidalgo MJ
Med Clin (Barc); 2013 Jul; 141 Suppl 1():30-4. PubMed ID: 24314565
[TBL] [Abstract][Full Text] [Related]
13. [Management of abnormal uterine bleeding].
Gaetje R; Scharl A; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Aug; 128(4):196-201. PubMed ID: 16835813
[TBL] [Abstract][Full Text] [Related]
14. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
[TBL] [Abstract][Full Text] [Related]
15. Patient satisfaction for levonorgestrel intrauterine system and norethisterone for treatment of dysfunctional uterine bleeding.
Naqaish T; Rizvi F; Khan A; Afzal M
J Ayub Med Coll Abbottabad; 2012; 24(1):23-6. PubMed ID: 23855088
[TBL] [Abstract][Full Text] [Related]
16. The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement.
Kilic S; Yuksel B; Doganay M; Bardakci H; Akinsu F; Uzunlar O; Mollamahutoglu L
Contraception; 2009 Aug; 80(2):152-7. PubMed ID: 19631790
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
[TBL] [Abstract][Full Text] [Related]
18. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
[TBL] [Abstract][Full Text] [Related]
19. [Thermal balloon endometrial ablation for dysfunctional uterine bleeding: technical aspects and results. A prospective cohort study of 152 cases].
Kdous M; Jacob D; Gervaise A; Risk E; Sauvanet E
Tunis Med; 2008 May; 86(5):473-8. PubMed ID: 19469303
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional uterine bleeding.
Farrell E
Aust Fam Physician; 2004 Nov; 33(11):906-8. PubMed ID: 15584330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
